$0.6000
At close: May 12, 10:40 AM EDT
$1.30
0.70116.67%
After Hours: May 26, 4:00 PM EDT
Comments
Loading...
Innovative MedTech Analyst Ratings and Price Targets | OTC:IMTH | Benzinga
Innovative MedTech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Innovative MedTech Corp from these most-recent analyst ratings.
Analyst Ratings for Innovative MedTech
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Innovative MedTech (IMTH) stock?
There is no price target for Innovative MedTech
What is the most recent analyst rating for Innovative MedTech (IMTH)?
There is no analyst for Innovative MedTech
When was the last upgrade for Innovative MedTech (IMTH)?
There is no last upgrade for Innovative MedTech
When was the last downgrade for Innovative MedTech (IMTH)?
There is no last downgrade for Innovative MedTech.
When is the next analyst rating going to be posted or updated for Innovative MedTech (IMTH)?
There is no next analyst rating for Innovative MedTech.
Is the Analyst Rating Innovative MedTech (IMTH) correct?
There is no next analyst rating for Innovative MedTech.
Browse analyst ratings and price targets on all stocks.
